(S)-N-((R)-1-acetyl-6-(quinolin-3-ylmethyl)-1,2,3,4-tetrahydroquinolin-4-yl)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanamide 2,2,2-trifluoroacetate

ID: ALA4550332

PubChem CID: 155555052

Max Phase: Preclinical

Molecular Formula: C34H35F3N4O5

Molecular Weight: 522.65

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)N1CC[C@@H](NC(=O)[C@@H](N)Cc2c(C)cc(O)cc2C)c2cc(Cc3cnc4ccccc4c3)ccc21.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C32H34N4O3.C2HF3O2/c1-19-12-25(38)13-20(2)26(19)17-28(33)32(39)35-30-10-11-36(21(3)37)31-9-8-22(16-27(30)31)14-23-15-24-6-4-5-7-29(24)34-18-23;3-2(4,5)1(6)7/h4-9,12-13,15-16,18,28,30,38H,10-11,14,17,33H2,1-3H3,(H,35,39);(H,6,7)/t28-,30+;/m0./s1

Standard InChI Key:  VLZAXVJRRJTXMP-VYVVXECBSA-N

Molfile:  

     RDKit          2D

 46 49  0  0  0  0  0  0  0  0999 V2000
   37.5124  -19.8584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2201  -19.4498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8047  -19.4498    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   37.5124  -20.6756    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   36.8025  -20.2629    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   38.9278  -19.8584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2201  -18.6326    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.1898  -18.3703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1886  -19.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8967  -19.5988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8949  -17.9614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6035  -18.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6023  -19.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3085  -19.5963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0204  -19.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0216  -18.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3108  -17.9551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4819  -17.9618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7743  -18.3706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0666  -17.9604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0721  -19.5948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7763  -19.1844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3109  -17.1379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0186  -16.7293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0186  -15.9121    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.7263  -17.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4340  -16.7293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7263  -17.9551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.1417  -17.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1370  -17.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8438  -18.3630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5525  -17.9544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5499  -17.1330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8425  -16.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8386  -15.9110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4280  -18.3609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2608  -18.3621    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.3593  -19.1866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3617  -18.3686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6556  -17.9592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9466  -18.3668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9481  -19.1879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6548  -19.5936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3062  -20.4135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5974  -20.8202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0128  -20.8241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  8  9  2  0
  9 10  1  0
 10 13  2  0
 12 11  2  0
 11  8  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  8 18  1  0
 18 19  1  0
 19 20  2  0
 20 39  1  0
 38 21  1  0
 21 22  2  0
 22 19  1  0
 17 23  1  6
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 26 28  1  6
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 34 35  1  0
 30 36  1  0
 32 37  1  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 38  2  0
 14 44  1  0
 44 45  1  0
 44 46  2  0
M  END

Associated Targets(Human)

OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oprm1 Mu opioid receptor (6060 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 522.65Molecular Weight (Monoisotopic): 522.2631AlogP: 4.63#Rotatable Bonds: 6
Polar Surface Area: 108.55Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.76CX Basic pKa: 8.05CX LogP: 4.12CX LogD: 3.50
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.34Np Likeness Score: -0.17

References

1. Nastase AF, Anand JP, Bender AM, Montgomery D, Griggs NW, Fernandez TJ, Jutkiewicz EM, Traynor JR, Mosberg HI..  (2019)  Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.,  62  (8): [PMID:30916966] [10.1021/acs.jmedchem.9b00378]

Source